Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|March 10, 2021
Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody NeutralizationPengfei Wang, Ryan G Casner, Manoj S Nair, et al.Cell Host & Microbe|April 22, 2021
Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralizationPengfei Wang, Ryan G Casner, Manoj S Nair, et al.Plos One|June 2, 2015
Cry protein crystals: a novel platform for protein deliveryManoj S Nair, Marianne M Lee, Astrid Bonnegarde-Bernard, et al.Nature Communications|April 2, 2021
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitorsSho Iketani, Farhad Forouhar, Hengrui Liu, et al.Biorxiv : the Preprint Server for Biology|August 15, 2020
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitorsSho Iketani, Farhad Forouhar, Hengrui Liu, et al.Cell Reports|November 3, 2021
An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infectionXiaohua Duan, Xuming Tang, Manoj S Nair, et al.Biorxiv : the Preprint Server for Biology|July 7, 2021
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domainGabriele Cerutti, Yicheng Guo, Pengfei Wang, et al.Iscience|March 17, 2023
Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boostManoj S Nair, Ruy M Ribeiro, Maple Wang, et al.Cell Reports|October 27, 2021
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domainGabriele Cerutti, Yicheng Guo, Pengfei Wang, et al.Nature Communications|July 4, 2025
Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2Qian Wang, Yicheng Guo, Ryan G Casner, et al.Pageof 6